Has Richard Gower received payments from drug or device companies?

Yes. Drug and device makers reported $103,669 in general payments to Richard Gower across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Gower did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Gower come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Gower

Allergy & Immunology · Spokane, WANPI 1619969557

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $69,255 of the $103,669 with a category attached, or 66.8%. 11 manufacturers reported payments, led by Shire North American Group Inc at 55.6% of the total. Reporting peaked in 2019 at $81,502 and has fallen 99.9% since, to $50 in 2023. Among allergy & immunology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$103,669in general payments, 2019–2025

Across 117 payments — averaging $886.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Shire North American Group Inc$58K
Biocryst US Sales Co., LLC$13K
Biocryst Pharmaceuticals, Inc.$12K
Pfizer$9K
Fresenius Kabi USA, LLC$6K
Takeda Pharmaceuticals U.S.A., Inc.$4K
plus $3K from 5 others

$1,023,354in research payments, 2019–2025

Across 311 payments — averaging $3290.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$361K
Incyte Corporation$270K
Biocryst Pharmaceuticals, Inc.$198K
Shire North American Group Inc$82K
Novartis$68K
Teva Pharmaceuticals USA, Inc.$28K
plus $17K from 4 others

What the payments were for

Consulting fees$21,62521%
Speaking & faculty fees$69,25567%
Travel & lodging$10,85310%
Food & beverage$1,9372%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Shire North American Group Inc	67	$57,678
Biocryst US Sales Co., LLC	13	$13,092
Biocryst Pharmaceuticals, Inc.	16	$11,841
Pfizer	7	$8,546
Fresenius Kabi USA, LLC	4	$5,798
Takeda Pharmaceuticals U.S.A., Inc.	3	$3,538
CSL Behring	2	$3,025
Optinose US, Inc.	1	$61
Pharming Healthcare, Inc.	2	$43
Sanofi	1	$24
AstraZeneca	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CINRYZE$60,260
Orladeyo$12,878
EUCRISA$8,505
PH-Icatibant$5,798
Haegarda$3,000

How this compares

$103,669 in reported general payments places this provider in the 95th percentile of 81 allergy & immunology providers in Washington.

See all allergy & immunology providers in Washington →

Other allergy & immunology in Spokane

Ronald EnglandSpokane$6K
Steven KernermanSpokane$3K
Kerry DrainSpokane$2K
Rayna TraenSpokane$1K
Taiil SongLakewood$192K
Frank VirantSeattle$107K
Leonard AltmanSeattle$81K
Daniel PetroniSeattle$68K
David McGarrySpokane Valley$66K
Rahool DaveSeattle$42K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →